⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 22, 2024Open Access

TABLE 1 from Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer

Jonathan Goldberg Na Qiao Jennifer L. Guerriero Brett Gross Yagiz Meneksedag Yoshimi F. Lu Anne V. Philips Tasnim Rahman Funda Meric‐Bernstam Jason Roszik Ken Chen Rinath Jeselsohn Sara M. Tolaney George E. Peoples Gheath Alatrash Elizabeth A. Mittendorf

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Identification of candidate ESR1-derived peptides

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Goldberg et al. (2024) studied this question.

synapsesocial.com/papers/68e781eeb6db6435876f4ec8 https://doi.org/10.1158/2767-9764.25266537.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1TABLE 1 from Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer2024
2TABLE 2 from Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer2024
3TABLE 2 from Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer2024
4Data from Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer2024
5Supplementary Figure S2 from Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer2024